Frank Schweizer

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 31

Top Topics

Pseudomonas Aeruginosa

Cancer Stem Cells

Silver Nanoparticles

Top Venues

RSC medicinal chemistry

Journal of medicinal chemistry

ACS infectious diseases

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Shiv Dhiman, Danyel Ramirez, Rajat Arora, Gilbert Arthur, Frank Schweizer
Enhancing outer membrane permeability of tetracycline antibiotics in P. aeruginosa using TOB-CIP conjugates. RSC medicinal chemistry (2024)
Danzel Marie Ramirez, Shiv Dhiman, Ayan Mukherjee, Ruwani Wimalasekara, Frank Schweizer
Application of tobramycin benzyl ether as an antibiotic adjuvant capable of sensitizing multidrug-resistant Gram-negative bacteria to rifampicin. RSC medicinal chemistry 15 (3) (2024)
Liam Berry, Danyel Ramirez, Ronald Domalaon, Frank Schweizer
Sulfonamide Bioisosteres of Niclosamide Enhance Antibacterial Activity of Colistin and Bacitracin. ChemMedChem (2024)
Liam Berry, Quinn Neale, Rajat Arora, Danyel Ramirez, Marc Brizuela, Ronald Domalaon, Gilbert Arthur, Frank Schweizer
Exploring Structure-Activity Relationships of Niclosamide-Based Colistin Potentiators in Colistin-Resistant Gram-Negative Bacteria. Antibiotics (Basel, Switzerland) 13 (1) (2024)
Liam Berry, Quinn Neale, Rajat Arora, Danyel Ramirez, Marc Brizuela, Ronald Domalaon, Gilbert Arthur, Frank Schweizer
Exploring Structure-Activity Relationships of Niclosamide-Based Colistin Potentiators in Colistin-Resistant Gram-Negative Bacteria. Antibiotics (Basel, Switzerland) 13 (1) (2024)
Shiv Dhiman, Danyel Ramirez, Rajat Arora, Gilbert Arthur, Frank Schweizer
Enhancing outer membrane permeability of tetracycline antibiotics in P. aeruginosa using TOB-CIP conjugates. RSC medicinal chemistry (2024)
Liam Berry, Danyel Ramirez, Ronald Domalaon, Frank Schweizer
Sulfonamide Bioisosteres of Niclosamide Enhance Antibacterial Activity of Colistin and Bacitracin. ChemMedChem 19 (15) (2024)
Danzel Marie Ramirez, Shiv Dhiman, Ayan Mukherjee, Ruwani Wimalasekara, Frank Schweizer
Application of tobramycin benzyl ether as an antibiotic adjuvant capable of sensitizing multidrug-resistant Gram-negative bacteria to rifampicin. RSC medicinal chemistry 15 (3) (2024)
Karan Gandhi, Shiv Dhiman, Rajat Arora, Danzel Marie Ramirez, Danyel Ramirez, Gilbert Arthur, Frank Schweizer
Exploring Antibiotic-Potentiating Effects of Tobramycin-Deferiprone Conjugates in Pseudomonas aeruginosa . Antibiotics (Basel, Switzerland) 12 (8) (2023)
Shiv Dhiman, Danyel Ramirez, Rajat Arora, Karan Gandhi, Ruwani Wimalasekara, Gilbert Arthur, Ayush Kumar, Frank Schweizer
Trimeric Tobramycin/Nebramine Synergizes β-Lactam Antibiotics against Pseudomonas aeruginosa . ACS omega 8 (32) (2023)
Shiv Dhiman, Danyel Ramirez, Yanqi Li, Ayush Kumar, Gilbert Arthur, Frank Schweizer
Chimeric Tobramycin-Based Adjuvant TOB-TOB-CIP Potentiates Fluoroquinolone and β-Lactam Antibiotics against Multidrug-Resistant Pseudomonas aeruginosa . ACS infectious diseases (2023)
Danzel Marie Ramirez, Danyel Ramirez, Shiv Dhiman, Rajat Arora, Christian Lozeau, Gilbert Arthur, George Zhanel, Frank Schweizer
Guanidinylated Amphiphilic Tobramycin Derivatives Synergize with β-Lactam/β-Lactamase Inhibitor Combinations against Pseudomonas aeruginosa . ACS infectious diseases (2023)
Mark William Nachtigal, Alon D Altman, Rajat Arora, Frank Schweizer, Gilbert Arthur
The Potential of Novel Lipid Agents for the Treatment of Chemotherapy-Resistant Human Epithelial Ovarian Cancer. Cancers 14 (14) (2022)
Noriyasu Hada, Tokio Morita, Takashi Ueda, Kazuki Masuda, Hiromi Nakane, Mami Ogane, Kimiaki Yamano, Frank Schweizer, Fumiyuki Kiuchi
Synthesis of the Carbohydrate Moiety of Glycoproteins from the Parasite Echinococcus granulosus and Their Antigenicity against Human Sera. Molecules (Basel, Switzerland) 26 (18) (2021)
Liam Berry, Marc Brizuela, Gregory Jackson, Frank Schweizer
A niclosamide-tobramycin hybrid adjuvant potentiates cefiderocol against P. aeruginosa. RSC medicinal chemistry 12 (9) (2021)
Danyel Ramirez, Liam Berry, Ronald Domalaon, Marc Brizuela, Frank Schweizer
Dilipid Ultrashort Tetrabasic Peptidomimetics Potentiate Novobiocin and Rifampicin Against Multidrug-Resistant Gram-Negative Bacteria. ACS infectious diseases 6 (6) (2020)
Frank Schweizer
Enhancing uptake of antibiotics into Gram-negative bacteria using nonribosome-targeting aminoglycoside-based adjuvants. Future medicinal chemistry 11 (13) (2020)
Temilolu Idowu, George G Zhanel, Frank Schweizer
A Dimer, but Not Monomer, of Tobramycin Potentiates Ceftolozane against Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa and Delays Resistance Development. Antimicrobial agents and chemotherapy 64 (3) (2020)
Ronald Domalaon, P Malaka De Silva, Ayush Kumar, George G Zhanel, Frank Schweizer
The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli. Antimicrobial agents and chemotherapy 63 (4) (2019)
Temilolu Idowu, Derek Ammeter, Heather Rossong, George G Zhanel, Frank Schweizer
Homodimeric Tobramycin Adjuvant Repurposes Novobiocin as an Effective Antibacterial Agent against Gram-Negative Bacteria. Journal of medicinal chemistry 62 (20) (2019)
Derek Ammeter, Temilolu Idowu, George G Zhanel, Frank Schweizer
Development of a nebramine-cyclam conjugate as an antibacterial adjuvant to potentiate β-lactam antibiotics against multidrug-resistant P. aeruginosa. The Journal of antibiotics 72 (11) (2019)
Liam Berry, Ronald Domalaon, Marc Brizuela, George G Zhanel, Frank Schweizer
Polybasic peptide-levofloxacin conjugates potentiate fluoroquinolones and other classes of antibiotics against multidrug-resistant Gram-negative bacteria. MedChemComm 10 (4) (2019)
Ronald Domalaon, Temilolu Idowu, George G Zhanel, Frank Schweizer
Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens? Clinical microbiology reviews 31 (2) (2018)
Ronald Domalaon, Marc Brizuela, Benjamin Eisner, Brandon Findlay, George G Zhanel, Frank Schweizer
Dilipid ultrashort cationic lipopeptides as adjuvants for chloramphenicol and other conventional antibiotics against Gram-negative bacteria. Amino acids 51 (3) (2018)
Ronald Domalaon, Yaroslav Sanchak, Linet Cherono Koskei, Yinfeng Lyu, George G Zhanel, Gilbert Arthur, Frank Schweizer
Short Proline-Rich Lipopeptide Potentiates Minocycline and Rifampin against Multidrug- and Extensively Drug-Resistant Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 62 (4) (2018)
Temilolu Idowu, Pranati Samadder, Gilbert Arthur, Frank Schweizer
Amphiphilic Modulation of Glycosylated Antitumor Ether Lipids Results in a Potent Triamino Scaffold against Epithelial Cancer Cell Lines and BT474 Cancer Stem Cells. Journal of medicinal chemistry 60 (23) (2017)
Ronald Domalaon, Xuan Yang, Yinfeng Lyu, George G Zhanel, Frank Schweizer
Polymyxin B3-Tobramycin Hybrids with Pseudomonas aeruginosa-Selective Antibacterial Activity and Strong Potentiation of Rifampicin, Minocycline, and Vancomycin. ACS infectious diseases 3 (12) (2017)
Makanjuola Ogunsina, Pranati Samadder, Temilolu Idowu, Gilbert Arthur, Frank Schweizer
Replacing d-Glucosamine with Its l-Enantiomer in Glycosylated Antitumor Ether Lipids (GAELs) Retains Cytotoxic Effects against Epithelial Cancer Cells and Cancer Stem Cells. Journal of medicinal chemistry 60 (5) (2017)
Yinfeng Lyu, Xuan Yang, Sudeep Goswami, Bala Kishan Gorityala, Temilolu Idowu, Ronald Domalaon, George G Zhanel, Anshan Shan, Frank Schweizer
Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline. Journal of medicinal chemistry 60 (9) (2017)
Xuan Yang, Sudeep Goswami, Bala Kishan Gorityala, Ronald Domalaon, Yinfeng Lyu, Ayush Kumar, George G Zhanel, Frank Schweizer
A Tobramycin Vector Enhances Synergy and Efficacy of Efflux Pump Inhibitors against Multidrug-Resistant Gram-Negative Bacteria. Journal of medicinal chemistry 60 (9) (2017)
Yinfeng Lyu, Ronald Domalaon, Xuan Yang, Frank Schweizer
Amphiphilic lysine conjugated to tobramycin synergizes legacy antibiotics against wild-type and multidrug-resistant Pseudomonas aeruginosa. Biopolymers (2017)